Some biotechnology stocks that provide ‘clear opportunities,’ J.P. Morgan says

J.P. Morgan analysts say it is too early to buy broadly into the biotechnology sector, but they identified several stocks in various categories that provide “clear opportunities” for selective investors.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.